v3.26.1
Condensed Consolidated Statements of Changes in Shareholders' Equity - USD ($)
$ in Thousands
Total
Series A Preferred Stock
Class A Common Stock
Preferred Stock
Series A Preferred Stock
Common stock
Common stock
Class A Common Stock
Common stock
Class B Common Stock
Retained earnings
Accumulated other comprehensive (loss) income
Non-controlling interest
Beginning balance (in shares) at Dec. 31, 2024       0            
Beginning balance at Dec. 31, 2024 $ 1,003,496     $ 0 $ 365,607     $ 715,767 $ (82,344) $ 4,466
Beginning balance (in shares) at Dec. 31, 2024           45,359,425 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 33,055             33,145   (90)
Other comprehensive income (loss) 20,830               20,830  
Issuance of restricted stock (in shares)           180,504        
Tax withholding related to vesting of restricted stock and other (3,471)       (3,471)          
Employee stock purchase program (in shares)           23,015        
Employee stock purchase program 659       659          
Stock option exercises (in shares)           123,137        
Stock option exercises 1,546       1,546          
Restricted stock compensation expense 13,612       13,612          
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 274             274    
Cash dividends - common (2,736)             (2,736)    
Ending balance (in shares) at Jun. 30, 2025       0            
Ending balance at Jun. 30, 2025 1,067,265     $ 0 377,953     746,450 (61,514) 4,376
Ending balance (in shares) at Jun. 30, 2025           45,686,081 0      
Beginning balance (in shares) at Mar. 31, 2025       0            
Beginning balance at Mar. 31, 2025 1,031,447     $ 0 370,513     724,215 (67,698) 4,417
Beginning balance (in shares) at Mar. 31, 2025           45,589,633 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 23,387             23,428   (41)
Other comprehensive income (loss) 6,184               6,184  
Issuance of restricted stock (in shares)           36,720        
Tax withholding related to vesting of restricted stock and other (293)       (293)          
Stock option exercises (in shares)           59,728        
Stock option exercises 788       788          
Restricted stock compensation expense 6,945       6,945          
Transfer from retained earnings to other assets for pro rata portion of equity method investee stock compensation expense 176             176    
Cash dividends - common (1,369)             (1,369)    
Ending balance (in shares) at Jun. 30, 2025       0            
Ending balance at Jun. 30, 2025 1,067,265     $ 0 377,953     746,450 (61,514) 4,376
Ending balance (in shares) at Jun. 30, 2025           45,686,081 0      
Beginning balance (in shares) at Dec. 31, 2025   100,000   100,000            
Beginning balance at Dec. 31, 2025 1,254,106     $ 96,266 388,389     809,885 (44,672) 4,238
Beginning balance (in shares) at Dec. 31, 2025     46,032,402     46,032,402      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 66,651             66,835   (184)
Other comprehensive income (loss) (7,896)               (7,896)  
Issuance of restricted stock (in shares)           191,470        
Tax withholding related to vesting of restricted stock and other (4,342)       (4,342)          
Employee stock purchase program (in shares)           17,665        
Employee stock purchase program 484       484          
Stock option exercises (in shares)           42,083        
Stock option exercises 595       595          
Restricted stock compensation expense 14,270       14,270          
Reclassification of accumulated other comprehensive income due to tax rate adjustment 13               13  
Cash dividends - preferred (4,188)             (4,188)    
Cash dividends - common (2,775)             (2,775)    
Ending balance (in shares) at Jun. 30, 2026   100,000   100,000            
Ending balance at Jun. 30, 2026 1,316,918     $ 96,266 399,396     869,757 (52,555) 4,054
Ending balance (in shares) at Jun. 30, 2026     46,283,620     46,283,620 0      
Beginning balance (in shares) at Mar. 31, 2026       100,000            
Beginning balance at Mar. 31, 2026 1,281,761     $ 96,266 392,258     836,444 (47,352) 4,145
Beginning balance (in shares) at Mar. 31, 2026           46,240,691 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Net income (loss) 36,704             36,795   (91)
Other comprehensive income (loss) (5,216)               (5,216)  
Issuance of restricted stock (in shares)           36,929        
Tax withholding related to vesting of restricted stock and other (348)       (348)          
Stock option exercises (in shares)           6,000        
Stock option exercises 96       96          
Restricted stock compensation expense 7,390       7,390          
Reclassification of accumulated other comprehensive income due to tax rate adjustment 13               13  
Cash dividends - preferred (2,094)             (2,094)    
Cash dividends - common (1,388)             (1,388)    
Ending balance (in shares) at Jun. 30, 2026   100,000   100,000            
Ending balance at Jun. 30, 2026 $ 1,316,918     $ 96,266 $ 399,396     $ 869,757 $ (52,555) $ 4,054
Ending balance (in shares) at Jun. 30, 2026     46,283,620     46,283,620 0